Clinical Trial: Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition:
Parkinson Disease
Multiple System Atrophy
Study Type: INTERVENTIONAL
Official Title: A Phase 2a, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Dosing of Exidavnemab in Patients With Mild to Moderate
Brief Summary:
The primary objective of this study is to assess the safety and tolerability of exidavnemab after multiple dosing versus placebo.
Read more